ARTICLE | Translation in Brief
Cytomegalovirus vectors for a prophylactic HIV vaccine
An engineered cytomegalovirus vector could provide the backbone for a prophylactic HIV vaccine
August 29, 2019 7:39 PM UTC
A spread-deficient cytomegalovirus carrying SIV antigens evoked long-term protective immunity against successive SIV infections in monkeys, suggesting that a prophylactic HIV vaccine can be developed in humans using a similar strategy.
While academics and companies are focusing on harnessing the immune system to eliminate the HIV virus postinfection, they are also looking at ways to prevent HIV infection...